ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote: What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote: What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote: What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote: What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more
Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more